Premium
Janus kinase inhibitor tofacitinib does not facilitate the repigmentation in mouse model of rhododendrol‐induced vitiligo
Author(s) -
Hayashi Masahiro,
Okamura Ken,
Abe Yuko,
Hozumi Yutaka,
Suzuki Tamio
Publication year - 2019
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/1346-8138.14879
Subject(s) - tofacitinib , vitiligo , janus kinase inhibitor , janus kinase , medicine , dermatology , pharmacology , immunology , receptor , rheumatoid arthritis